Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Guidelines on CVD prevention: confusing or complementary?

De Backer G, Catapano AL, Chapman J, Graham I, Reiner Z, Perk J, Wiklund O.

Atherosclerosis. 2013 Jan;226(1):299-300. doi: 10.1016/j.atherosclerosis.2012.10.042. Epub 2012 Oct 17. No abstract available.

PMID:
23102598
2.

Guidelines on CVD prevention: confusing or complementary?

De Backer G, Catapano AL, Chapman J, Graham I, Reiner Z, Perk J, Wiklund O.

Eur J Prev Cardiol. 2013 Feb;20(1):6-8. doi: 10.1177/2047487312464001. No abstract available.

PMID:
23258929
3.

Polish forum for prevention guidelines on cardiovascular diseases prevention in women.

Kornacewicz-Jach Z, Podolec P, Kopeć G, Pajak A, Zdrojewski T, Naruszewicz M, Stańczyk J, Undas A, Kozek E, Tykarski A, Opala G, Windak A, Torbicki A, Musiał J.

Kardiol Pol. 2007 Mar;65(3):334-7. English, Polish. No abstract available.

PMID:
17615665
4.

Polish Forum for Prevention of Cardiovascular Diseases Guidelines on prophylactic pharmacotherapy.

Podolec P, Kopeć G, Undas A, Pająk A, Godycki-Ćwirko M, Zdrojewski T, Jankowski P, Drygas W, Rynkiewicz A, Piotrowicz R, Czarnecka D, Naruszewicz M, Opala G, Stańczyk J, Kozek E, Windak A, Banasiak W, Guzik T; Polish Forum for Prevention of Cardiovascular Diseases Task Force on Guidelines.

Kardiol Pol. 2011;69(2):195-7. No abstract available.

5.

The next steps in developing clinical practice guidelines for prevention.

Gibbons GH, Harold JG, Jessup M, Robertson RM, Oetgen WJ.

Circulation. 2013 Oct 8;128(15):1716-7. doi: 10.1161/CIRCULATIONAHA.113.005548. Epub 2013 Aug 8. No abstract available.

6.

[Contemporary strategies of prevention and treatment of cardiovascular diseases].

Oganov RG, Pogosova GV.

Kardiologiia. 2007;47(12):4-9. Russian. No abstract available.

PMID:
18260971
7.

Joint societies CVD Prevention Guidelines launched in May 2012.

Taylor J.

Eur Heart J. 2012 Jul;33(13):1539. doi: 10.1093/eurheartj/ehs137.

8.

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GB, Ng D, Pearson GJ, Sniderman A, Stone JA, Ur E.

Can J Cardiol. 2009 Oct;25(10):567-79. Review.

9.

A comparative analysis of three widely used lipid management guidelines in the EPIC-Norfolk cohort.

Colkesen EB, Jørstad HT, Peters RJ, Boekholdt SM, Tijssen JG, Ferket BS, Wareham NJ, Khaw KT.

Eur J Prev Cardiol. 2013 Feb;20(1):98-106. doi: 10.1177/2047487311435456. Epub 2012 Jan 13.

PMID:
22345678
10.

Guidelines for prevention of CVD in women.

Watson K.

J Fam Pract. 2005 Jul;Suppl:7-8. Review. No abstract available.

PMID:
16134559
11.

CVD prevention in women: a practice update.

Campos-Outcalt D.

J Fam Pract. 2011 Jul;60(7):421-5. Review.

PMID:
21731920
12.
13.

Benchmarking progress in the implementation of the Fourth Joint Societies' Task Force Guidelines on the Prevention of Cardiovascular Disease in Clinical Practice.

Morgan K, Burke H, McGee H.

Eur J Prev Cardiol. 2013 Feb;20(1):54-60. doi: 10.1177/2047487311433858. Epub 2012 Jan 4.

PMID:
22345672
14.

Barriers to effective implementation of guideline recommendations.

Erhardt LR.

Am J Med. 2005 Dec;118 Suppl 12A:36-41.

PMID:
16356806
15.

US heart doctors defend new prevention guidelines.

McCarthy M.

BMJ. 2013 Nov 20;347:f6957. doi: 10.1136/bmj.f6957. No abstract available.

PMID:
24259332
16.

Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study.

Dallongeville J, Banegas JR, Tubach F, Guallar E, Borghi C, De Backer G, Halcox JP, Massó-González EL, Perk J, Sazova O, Steg PG, Artalejo FR; EURIKA Investigators.

Eur J Prev Cardiol. 2012 Jun;19(3):541-50. doi: 10.1177/1741826711407705. Epub 2011 Apr 18.

PMID:
21502280
17.
18.

Prevention of cardiovascular diseases in perimenopausal women and the influence of hormone replacement therapy: an evidence-based guideline.

Gebara OC, Fernandes C, Bertolami MC.

Arq Bras Cardiol. 2009 Nov;93(5):e86-8. No abstract available.

19.

Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.

Schmieder RE, Goebel M, Bramlage P.

Vasc Health Risk Manag. 2012;8:177-86. doi: 10.2147/VHRM.S29915. Epub 2012 Mar 15.

20.

When is the use of aspirin for CVD prevention in women appropriate?

Manson JE, Bassuk SS.

Menopause. 2014 Jan;21(1):103-5. doi: 10.1097/GME.0b013e318298d74e.

PMID:
23695505
Items per page

Supplemental Content

Write to the Help Desk